Immatics (IMTX) has had the highest return between November 8, 2015 and November 8, 2025 by a US stock in the Biotechnology Industry with a market cap of $1B+, returning 180,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immatics (IMTX) | 11/8/2015 - 11/8/2025 | 180,900% |
180 Life Sciences (ATNF) | 11/8/2015 - 11/8/2025 | 65,782.35% |
argenx NV ADR (ARGX) | 11/8/2015 - 11/8/2025 | 4,674.58% |
Regencell Bioscience (RGC) | 11/8/2015 - 11/8/2025 | 4,022.86% |
Natera (NTRA) | 11/8/2015 - 11/8/2025 | 2,085.87% |
Madrigal Pharmaceuticals (MDGL) | 11/8/2015 - 11/8/2025 | 2,050.59% |
Krystal Biotech (KRYS) | 11/8/2015 - 11/8/2025 | 1,785.05% |
Vericel Corp Ord (VCEL) | 11/8/2015 - 11/8/2025 | 1,702.78% |
Insmed (INSM) | 11/8/2015 - 11/8/2025 | 1,046.92% |
Ascendis Pharma A-S (ASND) | 11/8/2015 - 11/8/2025 | 1,012.15% |
BeiGene (ONC) | 11/8/2015 - 11/8/2025 | 1,004.49% |
Merus (MRUS) | 11/8/2015 - 11/8/2025 | 876.72% |
Abivax SA American Depositary Shares (ABVX) | 11/8/2015 - 11/8/2025 | 807.5% |
Belite Bio Inc ADR (BLTE) | 11/8/2015 - 11/8/2025 | 805.52% |
Arrowhead Pharmaceuticals (ARWR) | 11/8/2015 - 11/8/2025 | 637.41% |
Viking Therapeutics (VKTX) | 11/8/2015 - 11/8/2025 | 623.82% |
EXACT Sciences (EXAS) | 11/8/2015 - 11/8/2025 | 585.09% |
Catalyst Pharmaceuticals (CPRX) | 11/8/2015 - 11/8/2025 | 568.44% |
Protagonist Therapeutics (PTGX) | 11/8/2015 - 11/8/2025 | 562.83% |
Exelixis (EXEL) | 11/8/2015 - 11/8/2025 | 552.96% |
BioNTech SE (BNTX) | 11/8/2015 - 11/8/2025 | 525.09% |
Celcuity LLC (CELC) | 11/8/2015 - 11/8/2025 | 503.4% |
Veracyte (VCYT) | 11/8/2015 - 11/8/2025 | 497.42% |
Cytokinetics (CYTK) | 11/8/2015 - 11/8/2025 | 439.55% |
Mirum Pharmaceuticals (MIRM) | 11/8/2015 - 11/8/2025 | 423.92% |
